1. Home
  2. FRSH vs GPCR Comparison

FRSH vs GPCR Comparison

Compare FRSH & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

HOLD

Current Price

$10.36

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$53.36

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSH
GPCR
Founded
2010
2016
Country
United States
United States
Employees
4500
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
FRSH
GPCR
Price
$10.36
$53.36
Analyst Decision
Buy
Strong Buy
Analyst Count
15
12
Target Price
$14.86
$103.17
AVG Volume (30 Days)
27.7M
842.4K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
296.88
N/A
EPS
N/A
N/A
Revenue
$838,809,000.00
N/A
Revenue This Year
$16.30
N/A
Revenue Next Year
$14.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.43
N/A
52 Week Low
$6.79
$15.80
52 Week High
$15.06
$94.90

Technical Indicators

Market Signals
Indicator
FRSH
GPCR
Relative Strength Index (RSI) 58.33 64.30
Support Level $7.71 $36.11
Resistance Level $10.69 $57.23
Average True Range (ATR) 0.44 2.65
MACD 0.05 0.44
Stochastic Oscillator 73.94 70.94

Price Performance

Historical Comparison
FRSH
GPCR

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions. It derives maximum revenue from North America.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: